NM_002386.4:c.586T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002386.4(MC1R):​c.586T>C​(p.Phe196Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00192 in 1,606,684 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F196V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0094 ( 25 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 28 hom. )

Consequence

MC1R
NM_002386.4 missense

Scores

3
8
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 6.21

Publications

34 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007436037).
BP6
Variant 16-89919844-T-C is Benign according to our data. Variant chr16-89919844-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 321433.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00942 (1435/152310) while in subpopulation AFR AF = 0.0327 (1357/41562). AF 95% confidence interval is 0.0312. There are 25 homozygotes in GnomAd4. There are 667 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1435 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MC1RNM_002386.4 linkc.586T>C p.Phe196Leu missense_variant Exon 1 of 1 ENST00000555147.2 NP_002377.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MC1RENST00000555147.2 linkc.586T>C p.Phe196Leu missense_variant Exon 1 of 1 6 NM_002386.4 ENSP00000451605.1
ENSG00000198211ENST00000556922.1 linkc.586T>C p.Phe196Leu missense_variant Exon 1 of 5 2 ENSP00000451560.1

Frequencies

GnomAD3 genomes
AF:
0.00941
AC:
1432
AN:
152192
Hom.:
24
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0327
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00242
AC:
589
AN:
243276
AF XY:
0.00183
show subpopulations
Gnomad AFR exome
AF:
0.0340
Gnomad AMR exome
AF:
0.00125
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000108
Gnomad OTH exome
AF:
0.000668
GnomAD4 exome
AF:
0.00113
AC:
1649
AN:
1454374
Hom.:
28
Cov.:
35
AF XY:
0.00101
AC XY:
729
AN XY:
723736
show subpopulations
African (AFR)
AF:
0.0380
AC:
1271
AN:
33470
American (AMR)
AF:
0.00134
AC:
60
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26122
East Asian (EAS)
AF:
0.000428
AC:
17
AN:
39694
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46398
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5766
European-Non Finnish (NFE)
AF:
0.000151
AC:
168
AN:
1111666
Other (OTH)
AF:
0.00186
AC:
112
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
115
230
345
460
575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00942
AC:
1435
AN:
152310
Hom.:
25
Cov.:
33
AF XY:
0.00895
AC XY:
667
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0326
AC:
1357
AN:
41562
American (AMR)
AF:
0.00340
AC:
52
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5174
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68014
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
72
144
217
289
361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00509
Hom.:
8
Bravo
AF:
0.0111
ESP6500AA
AF:
0.0309
AC:
134
ESP6500EA
AF:
0.000470
AC:
4
ExAC
AF:
0.00297
AC:
360
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Sep 18, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MC1R: BP4, BS1, BS2 -

Nov 24, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23647022, 20876876, 18402696, 22547573, 16988943, 16595073, 16280005, 15979202, 12851329) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tyrosinase-positive oculocutaneous albinism;C1849452:SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2;C2751295:Melanoma, cutaneous malignant, susceptibility to, 5;C2751296:Increased analgesia from kappa-opioid receptor agonist, female-specific Benign:1
Aug 04, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MC1R-related disorder Benign:1
May 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.15
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
.;T;T;.
Eigen
Uncertain
0.25
Eigen_PC
Benign
0.10
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.93
D;.;D;D
MetaRNN
Benign
0.0074
T;T;T;T
MetaSVM
Uncertain
-0.12
T
MutationAssessor
Uncertain
2.8
.;M;M;.
PhyloP100
6.2
PROVEAN
Pathogenic
-5.6
D;.;D;N
REVEL
Uncertain
0.38
Sift
Pathogenic
0.0
D;.;D;D
Sift4G
Benign
0.065
T;.;T;D
Polyphen
1.0
.;D;D;.
Vest4
0.74
MutPred
0.29
Loss of helix (P = 0.3949);Loss of helix (P = 0.3949);Loss of helix (P = 0.3949);Loss of helix (P = 0.3949);
MVP
0.69
MPC
0.13
ClinPred
0.074
T
GERP RS
4.6
Varity_R
0.69
gMVP
0.51
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212366; hg19: chr16-89986252; COSMIC: COSV99043880; COSMIC: COSV99043880; API